NHS Approves First Major Stomach Cancer Drug in a Decade

Around 1,500 people with stomach cancer will gain access to a groundbreaking immunotherapy treatment that extends survival and reduces recurrence.

It's the first major advance in stomach cancer care in nearly ten years.